Position in MDXG
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,229,423
-$9,346,915 QoQ
Shares Held
2,842,892
-6.5% QoQ
Ownership
1.95%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026First Light Asset Management, LLC holds $648,580,707 across 12 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
930,289 | $123,477,258 | |
| 2 | PVLA |
Palvella Therapeutics, Inc.
|
771,901 | $117,961,910 | |
| 3 | TWST |
Twist Bioscience Corp
|
727,933 | $74,889,747 | |
| 4 | ELVN |
Enliven Therapeutics, Inc.
|
1,360,750 | $69,058,062 | |
| 5 | 1,360,866 | $50,923,605 | |||
| 6 | EWTX |
Edgewise Therapeutics, Inc.
|
1,095,171 | $44,496,797 | |
| 7 | ANAB |
Anaptysbio, Inc
|
582,004 | $39,285,270 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
2,097,215 | $39,113,059 |
All Filings in MDXG
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,229,423 | 2,842,892 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,576,338 | 3,039,341 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,497,604 | 3,652,952 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,776,988 | 1,927,494 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $26,243,362 | 3,453,074 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $32,167,942 | 3,343,861 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||